Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs
摘要:
The synthesis of a novel series of lamivudine prodrugs involving N-4-substitution with isatin derivatives is described. The in-vitro antiretroviral activities indicated that compound 3b was found to be equipotent to lamivudine with EC50 of 0.0742 +/- 0.04 mu M. Lamivudine prodrugs bearing fluoroquinoles antibacterial showed 92-100% inhibition against Mycobacterium tuberculosis strain H(37)Rv at 6.25 pg ml(-1). At pH 7.4, 37 degrees C, the hydrolytic t(1/2) ranged between 120 and 240 min. (c) 2005 Published by Elsevier SAS.
Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs
摘要:
The synthesis of a novel series of lamivudine prodrugs involving N-4-substitution with isatin derivatives is described. The in-vitro antiretroviral activities indicated that compound 3b was found to be equipotent to lamivudine with EC50 of 0.0742 +/- 0.04 mu M. Lamivudine prodrugs bearing fluoroquinoles antibacterial showed 92-100% inhibition against Mycobacterium tuberculosis strain H(37)Rv at 6.25 pg ml(-1). At pH 7.4, 37 degrees C, the hydrolytic t(1/2) ranged between 120 and 240 min. (c) 2005 Published by Elsevier SAS.
The synthesis of a novel series of lamivudine prodrugs involving N-4-substitution with isatin derivatives is described. The in-vitro antiretroviral activities indicated that compound 3b was found to be equipotent to lamivudine with EC50 of 0.0742 +/- 0.04 mu M. Lamivudine prodrugs bearing fluoroquinoles antibacterial showed 92-100% inhibition against Mycobacterium tuberculosis strain H(37)Rv at 6.25 pg ml(-1). At pH 7.4, 37 degrees C, the hydrolytic t(1/2) ranged between 120 and 240 min. (c) 2005 Published by Elsevier SAS.